MoneyWorks4Me

JFL Life Sciences - Quaterly Results

08 Apr 2025 Evaluate
The total revenue for the December 2024 quarter zoomed 279.50% to Rs. 212.48 millions as compared to Rs. 55.99 millions during the year-ago period.The Net Profit of the company vaulted to 155.86% to Rs. 7.42  millions from Rs. 2.90 millions in the previous quarter.Operating Profit saw a handsome growth to 13.52 millions from 8.30 millions in the quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 212.48 55.99 279.50 212.48 55.99 279.50 465.50 428.30 8.69
Other Income 0.10 4.16 -97.60 0.10 4.16 -97.60 5.20 16.40 -68.29
PBIDT 13.52 8.30 62.89 13.52 8.30 62.89 50.70 55.70 -8.98
Interest 2.01 3.70 -45.68 2.01 3.70 -45.68 8.30 14.20 -41.55
PBDT 11.51 4.60 150.22 11.51 4.60 150.22 42.40 41.50 2.17
Depreciation 1.59 1.26 26.19 1.59 1.26 26.19 4.40 4.30 2.33
PBT 9.92 3.34 197.01 9.92 3.34 197.01 38.00 37.20 2.15
TAX 2.50 0.44 468.18 2.50 0.44 468.18 4.90 9.10 -46.15
Deferred Tax 0.07 -0.30 -123.33 0.07 -0.30 -123.33 -3.00 0.00 0.00
PAT 7.42 2.90 155.86 7.42 2.90 155.86 33.10 28.10 17.79
Equity 329.95 109.98 200.01 329.95 109.98 200.01 110.00 110.00 0.00
PBIDTM(%) 6.36 14.82 -57.08 6.36 14.82 -57.08 10.89 13.00 -16.25
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..